Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #3 of 4 in 2020

Macquarie University Centre for the Health Economy; Martin Hoyle

Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #3 of 4 in 2020

Macquarie University Centre for the Health Economy, Martin Hoyle

Research output: Book/Report › Other report

Original language	English
Publisher	Australian Government Department of Health
Publication status	Published - 2020

Cite this

@book{d0d2a79f89994ba9b7f1da42813f77ce,

title = "Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #3 of 4 in 2020",

author = "{Macquarie University Centre for the Health Economy} and Martin Hoyle",

year = "2020",

language = "English",

publisher = "Australian Government Department of Health",

}

TY - BOOK

T1 - Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #3 of 4 in 2020

AU - Macquarie University Centre for the Health Economy

AU - Hoyle, Martin

PY - 2020

Y1 - 2020

M3 - Other report

BT - Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #3 of 4 in 2020

PB - Australian Government Department of Health

ER -